Antibiotic resistance has become a major healthcare challenge worldwide. Avibactam uses have expanded significantly because this novel beta-lactamase inhibitor helps restore the effectiveness of antibiotics against resistant gram-negative bacteria. Unlike traditional beta-lactamase inhibitors, avibactam blocks several important resistance enzymes, making it an essential component of modern antimicrobial therapy. Healthcare professionals commonly use avibactam in combination...Read More

Gram-negative bacteria are among the most clinically significant pathogens in modern medicine. They are responsible for a wide range of infections, from uncomplicated urinary tract infections (UTIs) to life-threatening bloodstream infections and hospital-acquired pneumonia. Over the past decade, the increasing prevalence of multidrug-resistant (MDR) gram-negative organisms has made treatment increasingly complex, posing a major challenge...Read More